ACBHighly likely offers were made to buy in for ACB but price was too low and rejected, think beverage, alcohol AND big pharma will partner up, hope its sooner than later, Linton said pharma will make their move later 2019. Its pay now or pay more later if sp holds up. You know Altria used the rolling daily average for the buy in price for Cronos when there had been coordinated short attacks on the mj sector. Long ACB, glta.